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Abstract 
THPGV-0 has antibacterial activity against S. aureus and B. subtilis at concentration 5 mg/mL and no activity 
againts E. coli until concentration 10 mg/mL. THPGV-1 has antibacterial activity againts S. aureus, E. coli, and 
B. Subtilis at concentration 0.5 mg/mL, 1 mg/mL and 0.5 mg/mL. While PGV-1 has activity at concentration 0.5 
mg/mL, 5 mg/mL and 1 mg/mL against S. aureus, E. coli and B. Subtilis but with smaller zone of inhibition. 
THPGV-1 is better antibacterial agent than THPGV-0. THPGV-1 is a better antibacterial agent compared to 
PGV-1. 
Keywords: antibacterial activity, tetrahydropentagamavunon-0 (THPGV-0), tetrahydropentagamavunon-1 
(THPGV-1), Pentagamavunon-0 (PGV-0) , Pentagamavunon-1 (PGV-1) 
 
1. Introduction 
Tetrahydrocurcumin (THC) is one of curcumin metabolites which also known as curcuminoids. Antibacterial 
activity of curcuminoids have been investigated by some researchers around the world like Naz’s result (2010) 
showed that B. subtilis was the most sensitive to turmeric extracts of curcuminoids. THC itself is normally 
isolated together with curcumin from turmeric, the yellow curry ingredient. From other 
publication, tetrahydrocurcumin, hexahydrocurcumin and octahydrocurcumin, the synthesized hydrogenated 
derivatives of curcumin, were evaluated for antibacterial activity by agar diffusion method against medically 
important bacteria viz. B. subtilis, K. pneumonia, E. coli, Enterobacter aerogenes, Pseudomonas aeruginosa, S. 
auresus and P. mirabili. (Singh and Jain, 2012) THC can be made synthetically by hydrogenation reaction of 
curcumin by using palladium on carbon as catalyst and hydrogen gas as source of hydrogen. THC also can be 
produced by microbial conversion of curcumin. (Maehara et al., 2011)  
Tetrahydropentagamvunon-0 (THPGV-0) is one of curcumin metabolite analog, THC. The biological activity of 
THPGV-0 has been investigated like in the histamine release from antigen-induced RBL-2H3 (Nugroho et al., 
2010). In this research, THPGV-0 is made by the hydrogenation method from Pentagamavunon-0 (PGV-0) in 
Faculty of Pharmacy, Gadjah Mada University. (Ritmaleni and Simbara, 2010) In this result, the hydrogenation 
reaction not only gave the THPGV-0 but also three other side products and their structure also have been 
identified. (Ritmaleni et al., 2013)  
As analog of THC, THPGV-0 has a similarity of structure to THC and the difference only on the middle 
functional group. According to the structure activity relationship base knowledge, THPGV-0 might have the 
biological activity like THC’s. Previous result showed, Pentagamavunon-0 (PGV-1) only active as antibacterial 
agent againts S. aureus with 9 mm of diameter of inhibition on 1 mg/mL of concentration. (Sardjiman, 2000) 
PGV-0 and PGV-1 are two among some patented compounds by Faculty of Pharmacy, Gadjah Mada University. 
(Sardjiman et al., 2003; Sardjiman et al., 2004) The aim of this research is to investigate the antibacterial activity 
of THPGV-0 and THPGV-1. 
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Figure 1. Structure of THC, THPGV-0 and THPGV-1 
 
 
Journal of Natural Sciences Research                                                                                                                                                www.iiste.org 
ISSN 2224-3186 (Paper)   ISSN 2225-0921 (Online) 
Vol.3, No.11, 2013 
 
13 
2. Experiment 
2.1 Synthesis of THPGV-0 
The synthesis is done according to the published method. (Ritmaleni and Simbara, 2010) 
To round bottom flask, PGV-0 (250.0 mg; 0.710 mmol) in methanol  (3 mL) was hydrogenated by hydrogen gas 
in baloon over  Palladium/carbon (Pd/C) 10 % for two hour. The reaction was an autoindicator reaction where 
indicating by colour changing from yellow to colourless. Then the mixture was filtered and the solvent was 
evaporated by using rotavapor. The products were separated by flash column Chromatography and purified by 
recrystallisation.  
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THPGV-0 
THPGV-0 was obtained as white crystals in 40 % yield,  m.p.  122.4 – 123.7 °C (EtOH : H2O = 2 : 1): 
1
H-NMR 
(500 MHz, ppm, aceton): 7.52 (2H, s, -OH x 2); δ 6.75 (2H, d, J= 1.8 Hz, H2′-Ph x 2); δ 6.70 (2H, m, H5′-Ph x 
2); δ 6.58 (2H, m, H6′-Ph x 2); δ 3.76 and 3.78 (6H, s, -OCH3 x 2); δ 2.97 and 2.85 (2H, dd, J= 4.25 and J=13.45 
Hz, H7′-a) [lit. (Ritmaleni and Simbara, 2010; δ 2.97 and 2.85 (2H, dd, J= 4.25 and J=13.45 Hz, H7′-a)) δ 2.97 
and 2.85 (2H, dd, J= 4.25 and J=13.45 Hz, H7′-a); δ 2.35 and 2,46 (2H, dd, J= 9.15 and J=13.45 Hz, H7′-b); δ 
2.26 (2H, dddd, J= 4.30; J= 7.95; J= 9.15; and J=11.65; H2&5); δ 1.89 and 1.80 (2H, dddd, J=3.05; J= 5.50; J= 
7.95; and 9.15 Hz, H3&4a); δ 1.39 and 1,55 (2H, dddd, J=3.05; J= 5.5; J= 9.15; and J= 11.60 Hz, H3&4b).  
2.2 Synthesis of THPGV-1 
The synthesis is done according to the published method (Ritmaleni et al., 2013) and the same as THPGV-0’s. 
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THPGV-1 
PGV-1 (250 mg; 0.718 mmol) in MeOH (3 mL), Pd/C (10 mol %; 76 mg), yield THPGV-1, as a white crystal 
product : 18 %; Rf = 0.40 (CHCl3:EtOAc = 20:1); mp = 133-135 °C  (ethanol: H2O = 2:1) IR (vmaks, cm
-1
, KBr): 
1723 (C=O), 2915 (C-H), 1442 (C-H); 
1
H-NMR (500 MHz, ppm, CDCl3): δ 6.76 (4H, s, H4-Ph x 4); 4.60 (2H, s, 
-OH x 2); 3.04 (1H, dd, J= 3,90 and J= 13,65 Hz, H6a); 2,92 (1H, dd, J= 3,90 and J= 13,60 Hz, H12); 2.47 (1H, 
dd, J= 9.10 dan J= 14.25 Hz, H6b); 2.52 – 2.41 (1H, m, H7); 2,32 (1H, dd, J= 9,70 and J= 13.60 Hz, H12); 2.25 
– 2.20 (1H, m, H10); 2.21 (12H, s, 4 X H1); 2.04 – 1.94 (1H, m, H9a); 1.87 (1H, dddd, J= 18.03; J= 12.10; 
J=8.50; J= 4.50 Hz, H8a); 1,58 (1H, dddd, J= 18.03; J= 12.90; J= 8.50; J= 4.50 Hz, H8b); 1.45 – 1.34 (1H, m, 
H9b); 
13
C-NMR (125 MHz, ppm, CDCl3): δ 220.2 (q), 150.7 (q), 150.69 (q); 131.57 (q) 131.53 (q); 129.24 (q) 
129.19 (q); 123.07 (d); 51.92 (d); 50.71 (d); 35.26 (t); 35.11 (t); 27.27 (t); 26.06 (t); 16.10 (q); MS (EI-MS, m/z); 
352,2 (40); 217.1 (20); 135,1(100); 161.1 (5); 55.1 (3) 
2.3 Antibacterial activity 
Before doing the test, all materials and equipments were sterilised with autoclaft at 121
 o
C for 20 minutes.  The 
antibacterial activities were evaluated by agar Diffusion Method (common published method) against three test 
bacteria: Staphylococcus aureus, Escherichia coli and Bacillus subtilis. The bacteria were cultivated on Nutrient 
agar (NA), incubated at 35
o
-37
o
C for 24 hours and moved to Nutrient Broth (NB) also incubated at 35
o
-37 
o
C for 
24 hours. Each compound was prepared in four different concentrations (0.5 mg/mL, 1 mg/mL, 5 mg/mL, 10 
mg/mL in DMSO). Amoxicilin was used as positive control. NA (10 mL) was melted which cooled to 40 
o
C and 
added 100 µL of bacterial suspension test, mixed homogenously. Mixture then was put into petri dish till densely. 
Four steril paper discs which contained 20 µL test solution was put onto that NA. In one petri dish, there were 10 
paper discs with 0.5 mg/mL, 1 mg/mL, 5 mg/mL and 10 mg/mL for THPGV-0 dan PGV-0, amoxicilin 0.5 
mg/mL and one paper disc for DMSO as control of solvent. The bacterial growth was optimised by incubating at 
37 
o
C for 18 – 24 h. Media control was prepared by using the same method without adding the bacterial 
suspension to see the differences of both media. The same method was used for PGV-1 and THPGV-1. 
 
3. Result and Discussion 
3.1 Antibacterial Activity of THPGV-0 
The antibacterial activity of THPGV-0 was compared to amoxicillin as positive control and PGV-0 as mother 
compound. THPGV-0 showed the activity at 5 mg/mL (6.69 mm) and 10 mg/mL (6.98 mm) againts S. aureus 
while PGV-0 did not show any activity. And amoxicillin at concentration 0.5 mg/mL showed 14.93 mm of zone 
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of inhibition. With agar diffusion method, THPGV-0 has a better antibacterial activity than PGV-0 at 5 mg/mL 
and 10 mg/mL against S. aureus with irradical zone of inhibition (Table 1). It can be concluded that THPGV-0 is 
a bacteriostatic agent. While amoxicillin is bactericidal, because it produced a radical zone of inhibition. 
Table 1. Antibacterial activity of THPGV-0 against S. aureus 
Concentration 
Zone of Inhibition (mm) 
PGV-0 THPGV-0 Amoxicillin DMSO 
0.5 mg/mL 
1 mg/mL 
5 mg/mL 
10 mg/mL 
6 
6 
6 
6 
6 
6 
6.69 
6.98 
14.93 
- 
- 
- 
 
6 
 
 
THPGV-0 did not show any activity against E. Coli (a gram negative) until concentration of 10 mg/mL and 
PGV-0 also did not. Amoxicillin which known as broad spectrum antibacterial agent can produce around 18.62 
mm of zone of inhibition (Table 2).  
Table 2. Antibacterial activity of THPGV-0 against E.coli 
Concentration 
Zone of Inhibition (mm) 
PGV-0 THPGV-0 Amoxicillin DMSO 
0.5 mg/mL 
1 mg/mL 
5 mg/mL 
10 mg/mL 
6 
6 
6 
6 
6 
6 
6 
6 
18.62 
- 
- 
- 
6 
 
Like againts S. aureus, THPGV-0 has antibacterial activity at concentration 5 mg/mL with zone of inhibition 
around 9.52 mm and 10 mg/mL, around 10.06 mm againts B. subtilis while amoxicillin at 0.5 mg/mL showed 
inhibition around 29.78 mm. And PGV-0 as mother compound did not show any inhibition at 10 mg/mL of 
concentration (Table 3). Because the zone of inhibition of THPGV-0 at 10 mg/mL of concentration is irradical, it 
can be concluded that this THPGV-0 is a bacteriostatic different from amoxicillin which is a bactericidal. 
Table 3. Antibacterial activity of THPGV-0 against B.subtilisi 
Concentration 
Zone of Inhibition (mm) 
PGV-0 THPGV-0 Amoxicillin DMSO 
0.5 mg/mL 
1 mg/mL 
5 mg/mL 
10 mg/mL 
6 
6 
6 
6 
6 
6 
9.52 
10.06 
29.78 
- 
- 
- 
 
6 
 
 
So, for THPGV-0 and PGV-0 antibacterial activity, THPGV-0 has a better activity at 5 mg/mL and 10 mg/mL of 
concentration against Gram positive bacteria, S. aureus and B. subtilis. 
3.2 Antibacterial Activity of THPGV-1 
Antibacterial activity of THPGV-1 was done as on THPGV-0. The lowest concentration was chosen as 0.5 
mg/mL according to the amoxicillin’s. In against S. aureus, THPGV-1 showed an activity at all series 
concentration as at 0.5 mg/mL, 1 mg/mL, 5 mg/mL and 10 mg/mL and zone of inhibition were around 8.69 mm; 
10.40 mm; 11.98 mm; and 12.08 mm respectively. PGV-1 as mother compound of THPGV-1 has activity started 
from concentration of 1 mg/mL with zone of inhibitions around 7.2 mm for 1 mg/mL, 10.92 mm for 5 mg/mL 
and 11.97 mm for 10 mg/mL. It can be seen from figure 4 that at concentration of 0.5 mg/mL, THPGV-1 showed 
an irradical zone of inhibition and this is enough to say that THPGV-1 is a bacteriostatic antibacterial agent and 
has a better activity that PGV-1. 
Table 4. Antibacterial activity of THPGV-1 against S. aureus 
Concentration 
Zone of Inhibition (mm) 
PGV-1 THPGV-1 Amoxicillin DMSO 
0.5 mg/mL 
1 mg/mL 
5 mg/mL 
10 mg/mL 
6.07 
7.20 
10.92 
11.97 
8.69 
10.40 
11.98 
12.08 
13.16 
- 
- 
- 
 
6 
 
 
Journal of Natural Sciences Research                                                                                                                                                www.iiste.org 
ISSN 2224-3186 (Paper)   ISSN 2225-0921 (Online) 
Vol.3, No.11, 2013 
 
15 
THPGV-1 and PGV-1 showed inhibitions at 5 mg/mL of concentration against E. Coli with zone of inhibition 
around 11.33 mm for THPGV-1 and 6.15 mm for PGV-1. At higher concentration, 10 mg/mL, zone of 
inhibitions were 12.71 mm for THPGV-1 and 8.65 mm for PGV-1. The zone of inhibition is irradical and this 
tell us that THPGV-1 is a bacteriostatic antibacterial agent and its activity is better than PGV-1 against E. Coli. 
Table 5. Antibacterial activity of THPGV-1 against E.coli 
Concentration 
Zone of Inhibition (mm) 
PGV-1 THPGV-1 Amoxicillin DMSO 
0.5 mg/mL 
1 mg/mL 
5 mg/mL 
10 mg/mL 
6 
6 
6.15 
8.65 
6 
7.52 
11.33 
12.71 
14.94 
- 
- 
- 
6 
 
Activity against B. Subtilis of THPGV-1 started from concentration of 0.5 mg/mL with zone of inhibition around 
6.15 mm and at 1 mg/mL around 7.90 mm, 5 mg/mL around 8.52 mm and 10 mg/mL around 10.20 mm. PGV-1 
gave inhibition at 1 mg/mL, 5 mg/mL and 10 mg/mL and its zone of inhibition respectively are 6.15 mm, 7.25 
mm and 7.73 mm. This data tell us that THPGV-1 is a better antibacterial agent compared to PGV-1 against B. 
Subtilis althought its activity is a bacteriostatic according to its irradical zone of inhibition.  
Table 6. Antibacterial activity of THPGV-0 against B.subtilisi 
Concentration 
Zone of Inhibition (mm) 
PGV-1 THPGV-1 Amoxicillin DMSO 
0.5 mg/mL 
1 mg/mL 
5 mg/mL 
10 mg/mL 
6 
6.15 
7.25 
7.73 
6.15 
7.90 
8.52 
10.20 
13.25 
- 
- 
- 
 
6 
 
 
The lowest concentration needed for inhibition of E. coli is higher than for S. aureus’. This is because E. coli as 
Gram negative bacteria has a complex cell wall compared to S. aureus as a Gram positive one. E. coli has an 
outer membran which built by lipopolysascharide(LPS), matrix porin and lipoprotein with their polar properties. 
(Madigan et al., 2003). This cause the polar compound can easily diffuse into the LPS membran. (Jawetz, 1996) 
Gram prositive bacteria is more sensitive to non-polar compound because its cell wall constructed by 
peptidoglycan with D-Alanin amino acid as one of its component. The non-polar compound will interact with 
phospholipid and cell membran of bacteria which can cause cell lysis. (Branen and Davidson, 1993) THPGV-0 
and THPGV-1 are more non-polar compared to their mother compounds, PGV-0 and PGV-1, that make their 
activities better on Gram positive bacteria like E. Coli.  
 
4. Conclusion 
Antibacterial activities of THPGV-0 and THPGV-1, by using agar diffusion method, are better than PGV-0 and 
PGV-1 and THPGV-1 has a better antibacterial activity compared to THPGV-0. 
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Figure 2. Antibacterial activity of THPGV-0 against S. aureus by using diffusion method, Red arrow showsthe 
activity on 5 mg/mL concentration of THPGV-0, blue arrow shows the activity on 10 mg/mL concentration of 
THPGV-0 and green arrow shows the activity on 0.5 mg/mL concentration of amoxicillin. 
 
    
 
Figure 3. Antibacterial activity of THPGV-0 against E. coli by using agar diffusion method. No activity  
showed by THPGV-0 and PGV-0. 
Journal of Natural Sciences Research                                                                                                                                                www.iiste.org 
ISSN 2224-3186 (Paper)   ISSN 2225-0921 (Online) 
Vol.3, No.11, 2013 
 
17 
 
Figure 4. Antibacterial activity of THPGV-0 against B. subtilis by using agar diffusion method. Red arrow 
shows the activity on 5 mg/mL concentration of THPGV-0, blue arrow shows the activity on 10 mg/mL 
concentration of THPGV-0 and green arrow shows the activity on 0.5 mg/mL concentration of amoxicilin. 
 
Figure 5. Antibacterial activity of THPGV-1 against S. aureus by using agar diffusion method. T1: THPGV-1 
0.5 mg/mLl, T2: THPGV-1 1 mg/mL, T3: THPGV-1 5 mg/mL, T4: THPGV-1 10 mg/mL, P1: PGV-1 0.5 
mg/mL, P2: PGV-1 1 mg/mL, P3: PGV-1 5 mg/mL, P4: PGV-1 10 mg/mL, A: Amoxicilin 0.5 mg/mL, D: 
DMSO 
 
Figure 6. Antibacterial activity of THPGV-0 against E. coli by using agar diffusion method. T1: THPGV-1 0.5 
mg/mLl, T2: THPGV-1 1 mg/mL, T3: THPGV-1 5 mg/mL, T4: THPGV-1 10 mg/mL, P1: PGV-1 0.5 mg/mL, 
P2: PGV-1 1 mg/mL, P3: PGV-1 5 mg/mL, P4: PGV-1 10 mg/mL, A: Amoxicilin 0.5 mg/mL, D: DMSO 
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Figure 7. Antibacterial activity of THPGV-0 against B. subtilis by using agar diffusion method. T1: THPGV-1 
0.5 mg/mLl, T2: THPGV-1 1 mg/mL, T3: THPGV-1 5 mg/mL, T4: THPGV-1 10 mg/mL, P1: PGV-1 0.5 
mg/mL, P2: PGV-1 1 mg/mL, P3: PGV-1 5 mg/mL, P4: PGV-1 10 mg/mL, A: Amoxicilin 0.5 mg/mL, D: 
DMSO 
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